Home › NDC Lookup › Ingredients › Dextromethorphan Hbr Guaifenesin › 11822-1812-02
mucus relief DM MAX dextromethorphan HBr, guaifenesin 1200 mg; 60 mg Tablet, Extended Release — NDC 11822-1812-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

mucus relief DM MAX dextromethorphan HBr, guaifenesin 1200 mg; 60 mg Tablet, Extended Release — NDC 11822-1812-2 (Billing 11822-1812-02)

by Rite Aid Corporation · 3 BOTTLE in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE

This is a package of mucus relief DM MAX dextromethorphan HBr, guaifenesin 1200 mg; 60 mg Tablet, Extended Release from Rite Aid Corporation, no longer marketed (first marketed Mar 2023), no longer in the FDA NDC Directory.

NDC 11822-1812-02
🏷️ FDA NDC (as labeled) 11822-1812-2 billing pads the package segment with a zero
This package
Contains14 tablet, extended release in 1 bottle Pack sizes3 compare ↓
Product page 11822-1812-00 Also comes in: 14 tablets 11822-1812-0 14 tablets 11822-1812-1
OTC Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11822-1812-2
Product NDC 11822-1812
11-digit billing NDC 11822181202
RxCUI 1099074
UNII 495W7451VQ, 9D2RTI9KYH
Application # ANDA207602
SPL Set ID a5fd7378-fd7b-400b-a374-0f3bee37702d
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2023-03-13
Marketing end 2026-12-31
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
Quick answers
  • RxCUI (RxNorm): 1099074
Why two NDCs? The FDA registers this code as 11822-1812-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 11822-1812-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 14 tablets 14 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11822-1812-00 11822-1812-0 Main listing 1 BOTTLE in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE 2023-03-13 Sep 30, 2026 Discontinued by firm
11822-1812-01 11822-1812-1 2 BOTTLE in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE 2023-03-16 Dec 31, 2026 Active
11822-1812-02 You're viewing this 3 BOTTLE in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE 2023-03-16 — Discontinued by firm

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 3 bottle in 1 carton / 14 tablet, extended release in 1 bottle.
What NDC number is used to bill for this package of mucus relief DM MAX dextromethorphan HBr, guaifenesin 1200 mg; 60 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Maximum Strength Guaifenesin DM 60 mg/1; 1200 mg 00536-1213-88 Rugby 14 tablets $0.545 — Discontinued —
Rugby Mucus Relief Dm Er 1200 mg/1; 60 mg 00536-1447-88 Rugby 14 tablets $0.545 — Availability likely —
good neighbor pharmacy mucus dm 1200 mg/1; 60 mg 46122-0637-03 Amerisource 28 tablets $0.545 — Availability likely —
Mucus Relief DM Extended Release Caplets 60 mg/1; 1200 mg 70000-0464-01 Cardinal 28 tablets $0.545 — Availability likely —
Mucus Relief DM 60 mg/1; 1200 mg 70677-1049-01 Strategic 1 tablet $0.545 — Availability likely —
Mucus Relief DM 60 mg/1; 1200 mg 83324-0137-14 QUALITY 1 tablet $0.545 — Availability likely —
Robitussin Maximum Strength 12 Hour Cough and Mucus Relief 60 mg/1; 1200 mg 00031-8765-04 Haleon 4 tablets — — FDA listed —
good sense mucus dm 1200 mg/1; 60 mg 00113-0812-03 L 1 tablet — — FDA listed —
Mucus Relief DM Extended Release Caplets Maximum Strength 60 mg/1; 1200 mg 00363-0437-14 Walgreens 14 tablets — — FDA listed —
Maximum Strength Mucus Relief DM 1200 mg/1; 60 mg 00363-0510-65 WALGREEN 7 tablets — — FDA listed —
mucus relief dm 1200 mg/1; 60 mg 00363-6812-30 Walgreen 28 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 11673-0267-05 Target 14 tablets — — FDA listed —
mucus relief DM MAX 1200 mg/1; 60 mgthis 11822-1812-02 Rite 14 tablets — — Discontinued —
Mucus Relief DM Maximum Strength 60 mg/1; 1200 mg 11822-7340-04 Rite 42 tablets — — FDA listed —
Guaifenesin and Dextromethorphan Hydrobromide HBR 1200 mg/1; 60 mg 11822-9996-01 RITE-AID 14 tablets — — FDA listed —
Mucus Relief DM MAXIMUM STRENGTH 1200 mg/1; 60 mg 21130-0989-03 Better 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 30142-0275-05 KROGER 7 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 1200 mg/1; 60 mg 30142-0963-14 Kroger 14 tablets — — FDA listed —
Topcare Mucus DM 1200 mg/1; 60 mg 36800-0592-30 Topco 28 tablets — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 37808-0730-42 H 42 tablets — — FDA listed —
mucus relief dm 60 mg/1; 1200 mg 37808-0812-66 H 14 tablets — — Discontinued —
Mucus Relief DM 60 mg/1; 1200 mg 37808-0834-14 H 14 tablets — — FDA listed —
Equaline Mucus DM 1200 mg/1; 60 mg 41163-0781-66 United 14 tablets — — FDA listed —
mucus dm 1200 mg/1; 60 mg 41250-0812-30 Meijer 28 tablets — — Discontinued —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 41415-0999-14 PUBLIX 14 tablets — — FDA listed —
mucus dm 60 mg/1; 1200 mg 42507-0812-66 HyVee 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 1200 mg/1; 60 mg 43598-0115-28 Dr. 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 1200 mg/1; 60 mg 43598-0232-37 Dr. 14 tablets — — FDA listed —
Mucus DM 1200 mg/1; 60 mg 46122-0420-03 Amerisource 7 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 60 mg/1; 1200 mg 49035-0824-28 EQUATE 28 tablets — — FDA listed —
Maximum Strength Mucus Relief DM 1200 mg/1; 60 mg 49035-0956-61 Wal-Mart 28 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 60 mg/1; 1200 mg 50090-6020-00 A-S 14 tablets — — FDA listed —
Mucinex DM Maximum Strength 1200 mg/1; 60 mg 50090-6549-00 A-S 14 tablets — — FDA listed —
Good Sense Mucus Dm 1200 mg/1; 60 mg 50090-7258-00 A-S 14 tablets — — FDA listed —
Rugby Mucus Relief Dm Er 1200 mg/1; 60 mg 50090-7891-00 A-S 14 tablets — — FDA listed —
Maximum Strength Cough And Congestion Extended Release 1200 mg/1; 60 mg 51316-0060-65 CVS 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan Hydrobromide 1200 mg/1; 60 mg 51316-0600-70 CVS 14 tablets — — FDA listed —
Mucus Relief Dm 1200 mg/1; 60 mg 51316-0671-55 CVS 42 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 51660-0110-54 OHM 14 tablets — — FDA listed —
Exchange Select Mucus DM 1200 mg/1; 60 mg 55301-0812-66 Army 14 tablets — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 55319-0734-07 Family 1 tablet — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 55319-0741-14 Family 1 tablet — — FDA listed —
DG health mucus dm 1200 mg/1; 60 mg 55910-0575-03 Dolgencorp, 1 tablet — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0715-05 Aurohealth 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0825-06 Aurohealth 7 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 58602-0849-11 Aurohealth 7 tablets — — FDA listed —
Mucus Relief DM 1200 mg/1; 60 mg 60000-0057-65 Ahold 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 63304-0110-54 SUN 14 tablets — — FDA listed —
Mucinex DM Maximum Strength 1200 mg/1; 60 mg 63824-0072-02 Reckitt 1 tablet — — FDA listed —
Mucus Relief DM Extended Release Caplets 60 mg/1; 1200 mg 63868-0870-14 QUALITY 14 tablets — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 63941-0734-14 Best 14 tablets — — FDA listed —
kirkland signature mucus dm 60 mg/1; 1200 mg 63981-0812-01 Costco 84 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 65162-0039-03 Amneal 30 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant Maximum Strength 1200 mg/1; 60 mg 67091-0315-14 Winco 7 tablets — — FDA listed —
Mucus Relief DM Maximum Strength 60 mg/1; 1200 mg 67091-0345-14 WinCo 14 tablets — — FDA listed —
Mucus Relief DM Maximum Strength 60 mg/1; 1200 mg 68016-0674-14 Chain 14 tablets — — FDA listed —
members mark mucus relief dm 1200 mg/1; 60 mg 68196-0812-45 Sam's 56 tablets — — FDA listed —
Members Mark Mucus Relief DM 1200 mg/1; 60 mg 68196-0999-56 SAM'S 14 tablets — — FDA listed —
Berkley and Jensen Mucus Relief DM 1200 mg/1; 60 mg 68391-0812-45 BJWC 56 tablets — — FDA listed —
Maximum Strength Mucus DM Extended Release 1200 mg/1; 60 mg 69842-0059-10 CVS 7 tablets — — FDA listed —
mucus dm extended release 1200 mg/1; 60 mg 69842-0812-30 CVS 28 tablets — — Discontinued —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 71179-0011-21 VESPYR 7 tablets — — FDA listed —
Mucus Relief DM 1200 mg/1; 60 mg 72036-0980-65 Harris 7 tablets — — FDA listed —
basic care mucus dm 1200 mg/1; 60 mg 72288-0812-55 Amazon.com 42 tablets — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 72476-0734-14 Care 14 tablets — — FDA listed —
Mucus Relief - Dm Maximum Strength 60 mg/1; 1200 mg 73581-0405-98 YYBA 98 tablets — — FDA listed —
Mucus Relief - Dm Maximum Strength 60 mg/1; 1200 mg 73581-0406-01 YYBA 100 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 1200 mg/1; 60 mg 76162-0032-56 TOPCO 7 tablets — — FDA listed —
Mucus Relief DM 60 mg/1; 1200 mg 81522-0734-14 FSA 1 tablet — — FDA listed —
Guaifenesin and Dextromethorphan HBr 1200 mg/1; 60 mg 85766-0046-28 Sportpharm 7 tablets — — FDA listed —
Mucus Dm Max 1200 mg/1; 60 mg 72288-0420-55 Amazon.com 42 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Mar 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Yellow
ShapeOval
ImprintL812
Size22 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRite Aid Corporation
Application holderPERRIGO R AND D CO
FDA applicationANDA207602 (ANDA)
Labeler code11822
First marketedMar 2023
Product typeHuman Otc Drug
Portfolio326 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 61 words ▾

Uses • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive • temporarily relieves: • cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants • the intensity of coughing • the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 60 words ▾

Directions • do not crush, chew, or break tablet • take with a full glass of water • this product can be administered without regard for timing of meals • adults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hours • children under 12 years of age: do not use

⚠️ Warnings 171 words ▾

Warnings Do not use • for children under 12 years of age • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus) When using this product • do not use more than directed Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 31 words ▾

Other information • each tablet contains: magnesium 25 mg • do not use if printed foil under cap is broken or missing • store between 20-25 ° C (68-77 ° F)

🧪 Active Ingredient 13 words ▾

Active ingredients (in each extended-release tablet) Dextromethorphan HBr 60 mg Guaifenesin 1200 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients carbomer homopolymer type B, copovidone, D&C yellow #10 aluminum lake, hypromellose, magnesium hydroxide, magnesium stearate, microcrystalline cellulose, silicon dioxide

🎯 Purpose 4 words ▾

Purposes Cough suppressant Expectorant

📄 Do Not Use 64 words ▾

Do not use • for children under 12 years of age • If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 31 words ▾

Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus)

📄 When Using This Product 11 words ▾

When using this product • do not use more than directed

📄 Stop Use and Ask a Doctor If 32 words ▾

Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 57 words ▾

Package/Label Principal Display Panel Compare to the active ingredients of Maximum Strength Mucinex ® DM FREE FROM GLUTEN FREE MAXIMUM STRENGTH MUCUS RELIEF DM MAX GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE EXTENDED-RELEASE TABLETS, 1200 mg / 60 mg EXPECTORANT & COUGH SUPPRESSANT Controls cough Thins and loosens mucus 12 HOUR ACTUAL SIZE 28 EXTENDED-RELEASE TABLETS mucus relief DM MAX-image

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for mucus relief DM MAX (this brand).

Top reported reactions

Dehydration1
Dry Skin1
Feeling Hot1
Hyperhidrosis1
Limb Discomfort1
Speech Disorder1
Tremor1

Reporter sex

1 reports
Male · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 14 tablets (11822-1812-00), 14 tablets (11822-1812-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Rite Aid Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 11822-1720-00 · Rite 11822-1879-01 · RITE →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.